Home › Breast Carcinoma In Situ › NCT06275126

Optimizing Surgical Decisions in Young Adults With Breast Cancer

Who can join

Ages 18 to 44 · Women

Inclusion Criteria:

* Female aged 18-44
* New diagnosis of Stage 0, 1, 2, or 3 unilateral breast cancer
* English or Spanish speaking

Exclusion Criteria:

* Diagnosis of de novo Stage 4 breast cancer
* Recurrent early-stage breast cancer
* Bilateral breast cancer

About the study

The goal of this study is to understand and improve the breast surgical decision-making process for young women newly diagnosed with breast cancer. As part of this study, the investigators will evaluate the impact and use a web-based tool called CONSYDER that is designed to provide useful information to young breast cancer patients. It is also meant to improve communication between young women and their surgeons with the purpose of helping patients make appropriate surgical decisions.

Participants will complete surveys approximately within 1 week of the surgical consult and approximately 6 months after surgery. Patients who receive neoadjuvant chemotherapy will also be surveyed after the completion of neoadjuvant treatment but prior to surgery. Some patients will be invited for an interview after their surgery as part of the evaluation. A subset of patients/surgeons will also have their surgical consultation audio-recorded.

What is being tested

• CONSYDER decision aid (other)

Sponsor: Weill Medical College of Cornell University · Participants: 800 · Started: Mar 13, 2024

Contact the study team

• Shoshana Rosenberg, ScD, MPH · Phone: 646-962-8041
• Darima Dorzhieva · Phone: 646-962-8666

Official record on ClinicalTrials.gov — NCT06275126

Locations in the U.S.

Conditions

• Breast Carcinoma In Situ
• Breast Cancer

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.